Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in ADPKD (TAME PKD)
NCT02656017Phase 2Completed
- Start
- Jun 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in autosomal dominant polycystic kidney disease (ADPKD). Started Jun 2016; status: completed.
02
Drugs
metformin
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT02656017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656017.